| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |